1.
Shahmirzadi NA, Zaboli P, Afzali M, Molla Tigabu B, Hajimiri M, Ajami A, Sepehri N. Economic Evaluations of Cabazitaxel for Treatment of Post-docetaxel Metastatic Castration-resistant Prostate Cancer: Evidence from a Systematic Review. JPRI [Internet]. 27Nov.2019 [cited 21Jan.2020];31(6):1-. Available from: http://journaljpri.com/index.php/JPRI/article/view/30324